Publicaciones en las que colabora con MARIONA JOVE FONT (145)

2023

  1. Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer's disease

    Alzheimer's research & therapy, Vol. 15, Núm. 1, pp. 134

  2. Changes in Plasma Neutral and Ether-Linked Lipids Are Associated with The Pathology and Progression of Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1728-1738

  3. Ether Lipid-Mediated Antioxidant Defense in Alzheimer’s Disease

    Antioxidants, Vol. 12, Núm. 2

  4. Gut microbiota links to serum ferritin and cognition

    Gut microbes, Vol. 15, Núm. 2, pp. 2290318

  5. Lipid Adaptations against Oxidative Challenge in the Healthy Adult Human Brain

    Antioxidants, Vol. 12, Núm. 1

  6. Lipidomic Alterations in the Cerebral Cortex and White Matter in Sporadic Alzheimer’s Disease

    Aging and Disease, Vol. 14, Núm. 5, pp. 1887-1916

  7. Lipidomic signature of stroke recurrence after transient ischemic attack

    Scientific Reports, Vol. 13, Núm. 1

  8. Low adherence to the Mediterranean diet is associated with increased prevalence and number of atherosclerotic plaques in the ILERVAS cohort

    Atherosclerosis, Vol. 380

  9. Metabolipidomic Analysis in Patients with Obstructive Sleep Apnea Discloses a Circulating Metabotype of Non-Dipping Blood Pressure

    Antioxidants, Vol. 12, Núm. 12

  10. Metabolomic Profiling in Children with Celiac Disease: Beyond the Gluten-Free Diet

    Nutrients, Vol. 15, Núm. 13

  11. Mitochondrial ROS production, oxidative stress and aging within and between species: Evidences and recent advances on this aging effector

    Experimental Gerontology, Vol. 174

  12. Phenotypic molecular features of long-lived animal species

    Free Radical Biology and Medicine, Vol. 208, pp. 728-747

  13. Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome

    Aging Cell, Vol. 22, Núm. 6

  14. Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease

    Redox Biology, Vol. 64

  15. Programmed versus non-programmed evolution of aging. What is the evidence?

    Experimental Gerontology, Vol. 175